GlassScriptPhysician profile
Carolina Roxana Marquez
NPI 1992381412
$4,219.14
in general payments reported to CMS, 2019-2025
17 companies · $2,373 in 2025
The $2,373 reported for 2025 was more than what 92% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,846 · 2025: $2,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,263 · Food and Beverage: $1,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,262.76 |
| Food and Beverage | $1,956.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $1,795.62 | 2024-2025 | |
| Treace Medical Concepts, INC. | $1,369.81 | 2025 | |
| Paratek Pharmaceuticals, INC. | $403.80 | 2025 | Nuzyra |
| Smith+Nephew, INC. | $190.26 | 2024-2025 | Memofix Super Elastic Nitinol Staple System, Collagenase Santyl, Bone Anchors With Arthroscopic Delivery System |
| Flower Orthopedics Coporation | $114.47 | 2025 | |
| Zimmer Biomet Holdings, INC. | $104.52 | 2025 | Accufill |
| Integra Lifesciences Corporation | $35.18 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $30.67 | 2025 | N/A |
| Solventum Corporation | $25.64 | 2024 | V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo |
| Surgenex LLC | $23.62 | 2025 | Pellograft, Surmatrix, Surgraft |
| Highridge Medical LLC | $22.73 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $22.73 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Bioventus LLC | $19.10 | 2024 | Exogen Ultrasound Bone Healing System |
| Dynasplint Systems INC. | $17.94 | 2024 | Dynasplint |
| Reprise Biomedical, INC. | $16.75 | 2025 | Miro3d |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $14.32 | 2024 | Qutenza |
| Orthofix Medical, INC. | $11.98 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolina Marquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.